Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01108523 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage
A Early Phase 1 study, sponsored by Healthpoint.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
NCT01108523 is a Early Phase 1 study that was terminated before completion, run by Healthpoint. The registered enrollment target is 7 participants.
The verdict
NCT01108523, a Early Phase 1 study, was terminated before completion, sponsored by Healthpoint.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study evaluates HP828 in the management of moisture associated skin damage after 15 days of use.
Interventions
- DEVICE HP828-101
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-02 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01108523
The ClinicalTrials.gov registry entry for NCT01108523 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HP828-101 is the first listed.
NCT01108523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01108523 about?
NCT01108523 is a clinical study titled "Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage". This study evaluates HP828 in the management of moisture associated skin damage after 15 days of use.
What is the current status of trial NCT01108523?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2010-04. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01108523?
The interventions under investigation include: HP828-101 (DEVICE).
Who is sponsoring clinical trial NCT01108523?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.